United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jun 30, 2026 · Filed Jul 1, 2026

On Jun 30, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$541.01 for US$5.14M under a trading plan, leaving 40,513 shares. Filed Jul 1, 2026 (Form 4).

Sold
9,500 shares
Price
US$541.01 average (US$536.28 to US$549.27)
Value
US$5.14M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 30, 2026Common StockOption exercise9,500US$135.4250,013Direct
Jun 30, 2026Common StockSale110US$536.2849,903Direct
Jun 30, 2026Common StockSale518US$537.7549,385Direct
Jun 30, 2026Common StockSale988US$538.5148,397Direct
Jun 30, 2026Common StockSale1,309US$539.9347,088Direct
Jun 30, 2026Common StockSale2,235US$540.7644,853Direct
Jun 30, 2026Common StockSale2,499US$541.6042,354Direct
Jun 30, 2026Common StockSale1,081US$542.6241,273Direct
Jun 30, 2026Common StockSale440US$543.3040,833Direct
Jun 30, 2026Common StockSale66US$545.9640,767Direct
Jun 30, 2026Common StockSale14US$546.6040,753Direct
Jun 30, 2026Common StockSale240US$549.2740,513Direct

Source

View original at SEC

Related